Chang Gung Memorial Hospital
Taoyuan, Taiwan, 333
NCT Number: NCT07642830
We will conduct a prospective, single-center observational study involving 60 adult T2D patients recruited from Chang Gung Memorial Hospital. Participants will be randomly allocated to either a CGM group or a control group receiving standard care. The intervention group will utilize mobile apps for medication tracking, and a remote communication platform. All participants will collect clinical data-including HbA1c, Time in Range (TIR), insulin use-at baseline and 12 weeks. Patient adherence and satisfaction with CGM will also be assessed.
Interested in participating?
Request Info20 year–75 year
All sexes
Interventional
Not applicable
Taoyuan, Taiwan, 333
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use CGM in the glucose monitoring for CGM arm
Time frame: From baseline to week 12
Change in HbA1c
Time frame: From baseline to week 12
Improvement in Time in Range
Chang Gung Memorial Hospital
Other
Clinical Research of Digital Health Solutions for Patients With Type 2 Diabetes
Acronym: DHS2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07678671
Diabetes Mellitus, Diabetes Mellitus Type 2
San Nicolás de los Garza, Nuevo León, Mexico
View Trial DetailsNCT06709040
Bone Diseases, Bone Diseases, Developmental
Glasgow, Scotland, United Kingdom
View Trial DetailsNCT07073768
Diabetes Mellitus, Diabetes Mellitus Type 2
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial DetailsNCT06846138
Diabetes Mellitus, Diabetes Mellitus Type 2
Riga, Latvia
View Trial Details